Publication date: Apr 12, 2019
The U. S. Centers for Disease Control and Prevention (CDC) has issued a letter clarifying that people suffering from severe pain caused by cancer or sickle-cell anemia should not be denied prescriptions for opioid pain-killers.
The letter, which was issued on Tuesday, emphasizes that the guidelines restricting the use of opioid medications were not intended to apply to patients undergoing cancer treatment or to any patients suffering from chronic pain.
Hematology society member Dr. Deepika Darbari, who treats young patients with sickle cell anemia reports that she has experienced insurers who refuse to cover IV opioids for patients experiencing severe pain, based on the CDC guidelines.
Now, the CDC has published a letter clarifying that the guidelines were never intended to deny such patients the painkillers, after three medical societies (the American Society of Hematology, the American Society of Clinical Oncology [ASCO] and the National Comprehensive Cancer Network [NCCN]) brought the problem to the agency’s attention.
|disease||MESH||sickle cell anemia|
|disease||DOID||sickle cell anemia|
- CDC clarifies opioid prescribing guideline, says doctors should use their ‘clinical judgement’
- CDC Clarifies: Okay to Prescribe Opioids for Cancer Pain
- Opioid Use: Study Finds Drop In Prescriptions
- Evaluating Chronic Pain Self-Management Support With an Opioid De-prescribing Intervention
- To address the opioid crisis we need to do more to support people suffering from opioid use disorder
- Pain patients say they’re falling through cracks in opioid legislation
- The Opioid Crisis: The Important Role of CPAs
- CDC’s Guideline for Prescribing Opioids for Chronic Pain